94 related articles for article (PubMed ID: 3590000)
1. [Rehabilitation of patients with gout during outpatient follow-up].
Ivanova MM; Novoselova TM; Akimova TF; Tsurko VV
Ter Arkh; 1987; 59(4):28-31. PubMed ID: 3590000
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?
Li-Yu J; Clayburne G; Sieck M; Beutler A; Rull M; Eisner E; Schumacher HR
J Rheumatol; 2001 Mar; 28(3):577-80. PubMed ID: 11296962
[TBL] [Abstract][Full Text] [Related]
3. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
[TBL] [Abstract][Full Text] [Related]
4. Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study.
Schumacher HR; Becker MA; Lloyd E; MacDonald PA; Lademacher C
Rheumatology (Oxford); 2009 Feb; 48(2):188-94. PubMed ID: 19141576
[TBL] [Abstract][Full Text] [Related]
5. [Gout: current views. Stage oriented treatment].
Fedorova NE; Grigor'eva VD
Klin Med (Mosk); 2002; 80(2):9-13. PubMed ID: 11898731
[TBL] [Abstract][Full Text] [Related]
6. Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: a prospective study.
Perez-Ruiz F; Atxotegi J; Hernando I; Calabozo M; Nolla JM
Arthritis Rheum; 2006 Oct; 55(5):786-90. PubMed ID: 17013833
[TBL] [Abstract][Full Text] [Related]
7. Hyperuricemia and gout.
Sloan RW
J Fam Pract; 1982 May; 14(5):923-6, 930-1, 934. PubMed ID: 7042900
[TBL] [Abstract][Full Text] [Related]
8. Updates in the management of gout.
Keith MP; Gilliland WR
Am J Med; 2007 Mar; 120(3):221-4. PubMed ID: 17349440
[TBL] [Abstract][Full Text] [Related]
9. The diagnosis and management of gouty arthritis.
Edwards NL
Compr Ther; 1983 Sep; 9(9):14-9. PubMed ID: 6627900
[No Abstract] [Full Text] [Related]
10. Serum urate levels and gout flares: analysis from managed care data.
Sarawate CA; Patel PA; Schumacher HR; Yang W; Brewer KK; Bakst AW
J Clin Rheumatol; 2006 Apr; 12(2):61-5. PubMed ID: 16601538
[TBL] [Abstract][Full Text] [Related]
11. Antihyperuricemic properties of amflutizole in gout.
Wortmann RL; Ridolfo AS; Lightfoot RW; Fox IH
J Rheumatol; 1985 Jun; 12(3):540-3. PubMed ID: 3900392
[TBL] [Abstract][Full Text] [Related]
12. Long-term cardiovascular mortality among middle-aged men with gout.
Krishnan E; Svendsen K; Neaton JD; Grandits G; Kuller LH;
Arch Intern Med; 2008 May; 168(10):1104-10. PubMed ID: 18504339
[TBL] [Abstract][Full Text] [Related]
13. Gouty arthritis. A primer on late-onset gout.
Ene-Stroescu D; Gorbien MJ
Geriatrics; 2005 Jul; 60(7):24-31. PubMed ID: 16026179
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of hyperuricemia and gout].
Pöllmann G; Kullich W; Klein G
Wien Med Wochenschr; 1997; 147(16):382-7. PubMed ID: 9446417
[TBL] [Abstract][Full Text] [Related]
15. Opportunities for improving medication use and monitoring in gout.
Singh JA; Hodges JS; Asch SM
Ann Rheum Dis; 2009 Aug; 68(8):1265-70. PubMed ID: 18701554
[TBL] [Abstract][Full Text] [Related]
16. Arthroscopic elimination of monosodium urate deposition of the first metatarsophalangeal joint reduces the recurrence of gout.
Wang CC; Lien SB; Huang GS; Pan RY; Shen HC; Kuo CL; Shen PH; Lee CH
Arthroscopy; 2009 Feb; 25(2):153-8. PubMed ID: 19171274
[TBL] [Abstract][Full Text] [Related]
17. Emerging therapies in the long-term management of hyperuricaemia and gout.
Stamp LK; O'Donnell JL; Chapman PT
Intern Med J; 2007 Apr; 37(4):258-66. PubMed ID: 17388867
[TBL] [Abstract][Full Text] [Related]
18. The management of gout at an academic healthcare center in Beijing: a physician survey.
Fang W; Zeng X; Li M; Chen LX; Schumacher HR; Zhang F
J Rheumatol; 2006 Oct; 33(10):2041-9. PubMed ID: 17014019
[TBL] [Abstract][Full Text] [Related]
19. [Gouty attacks in hyperuricemic hypertensives. A follow-up study (author's transl)].
Tofuku Y; Kuroda M; Takeda R
Ryumachi; 1977 May; 17(3):298-303. PubMed ID: 918776
[No Abstract] [Full Text] [Related]
20. The effect of control and self-medication of chronic gout in a developing country. Outcome after 10 years.
Darmawan J; Rasker JJ; Nuralim H
J Rheumatol; 2003 Nov; 30(11):2437-43. PubMed ID: 14677190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
